Arcadia Medicine is a biotechnology company that creates psychedelic medicine to treat mental health issues.
Arcadia Medicine has raised $9.3M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Arcadia Medicine's investors include Sam Altman, Dylan Field, Fred Ehrsam.
Arcadia Medicine is headquartered in San Francisco, United States.
Arcadia Medicine is a biotechnology company that creates psychedelic medicine to treat mental health issues.
Arcadia Medicine is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Arcadia Medicine — Funding & Investors." VCBacked, October 6, 2025, https://www.vcbacked.co/company/arcadia-medicine. Accessed August 30, 2026.
VCBacked. (2025). Arcadia Medicine — Funding & Investors. Retrieved August 30, 2026, from https://www.vcbacked.co/company/arcadia-medicine
{{cite web |title=Arcadia Medicine — Funding & Investors |url=https://www.vcbacked.co/company/arcadia-medicine |website=VCBacked |access-date=August 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated